NIOX-Guided Assessment

Treatment

Patient counselled on the importance of consistent adherence to inhaled controller medication to bring airway inflammation into the normal range

Prescribed an inhaled steroid with a once-daily dosing regimen to encourage better adherence

Follow-Up

6-week follow-up visit revealed good asthma control (ACT = 24), exercise tolerance, and normal lung function, however, adherence with ICS inhaler is still only 50%

Significant improvement in spirometry as indicated by changes in all parameters

FeNO value was modestly reduced to 70 ppb

Further follow-up was planned for 2 to 3 months to recheck FeNO, ICS use, and inhaler adherence

Investigation of the patient’s inhaler revealed that over the 6 weeks, only 32 of the 60 doses had been used. Non-adherence due to significant deficiencies in the patient’s inhalation technique were discovered, so correct use of the device was demonstrated.

By clicking Yes you will be taken to a third-party website or websites to which Circassia's Privacy Policy and other rules do not apply. Circassia is not responsible for the privacy policy of any third-party websites. You are solely responsible for interactions with such third-party website(s).